G80
Conditions
Interventions
Group 1: Intervention group: Patients in the intervention group will undergo SEMLS with rectus femoris muscle transposition in addition to DFESO and PTS.
Group 2: Control group: Patients in the contro
Sponsors
Universitätsklinikum Heidelberg, Klinik für Orthopädie und Unfallchirurgie
Eligibility
Sex/Gender
All
Age
6 Years to 16 Years
Inclusion criteria
Inclusion criteria: Children and adolescents diagnosed with spastic bilateral cerebral palsy (GMFCS Level I-II) and crouch gait, patella alta, parent/legal guardian consent to the study participation of minors, participation with standardized clinical examination and instrumental 3D gait analysis at E0, E1, E2 and E3.
Exclusion criteria
Exclusion criteria: Previous operations on the lower extremities, patient or guardian desire to withdraw from the study, Botulinum toxin therapy within the last 6 months, recent antispastic medical therapy, non-compliance with therapy or follow-up, patellar stress fractures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantitative effects on the degree of knee extension-flexion and pelvic tilting during the gait cycle, as measured with 3D gait analysis immediately before (E0) and 1 (E1), 2 (E2), and 5 (E3) years after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Effects on the following parameters at E0, E1, E2, and E3: Range of motion of the lower extremities. Quantitative and qualitative imaging findings (e.g., Koshino-Index, pseudoarthrosis signs, etc). Strength (Biodex strength assessment) and spasticity (electromyography). | — |
Countries
Germany
Contacts
Public ContactPablo Hartmann
Universitätsklinikum Heidelberg: Orthopädische Klinik
Outcome results
None listed